Rangeley Capital, LLC

SEC CIK: 0001517796
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

SAGE holding history

Sage Therapeutics, Inc. in every 13F filed by Rangeley Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SAGE overview All 13F holders of SAGE Full Q2 2026 holdings

Shares (Q3 2025): 0; Sold out in Q3 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2025

Holdings of SAGE by Rangeley Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	0	$0	0.0%	−730,000−100.0%	Sold out	Holders
Q2 2025	730,000	$6.66M	8.4%	+345,313+89.8%	Added	Holders
Q1 2025	384,687	$3.06M	3.5%	+384,687	New	Holders